| Standard therapy for patients with myelodysplastic syndromes. | |
| | |
MedLine Citation:
|
PMID: 21816368 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders characterized by cytopenias, dysplastic changes in the hematopoietic precursors, and an increased risk of evolving into acute leukemia. Treatment for patients with MDS ranges from supportive care with blood products and/or growth factors up to allogeneic stem cell transplantation. Over the past decade, several novel therapeutic agents have been approved for clinical use. In this article, the current approach for the management of patients with MDS according to their risk category is described and mainly focuses on approved novel agents. |
| | |
Authors:
|
Ali Al-Ameri; Mohamad Cherry; Guillermo Garcia-Manero; Alfonso Quintás-Cardama |
Related Documents
:
|
21273078 - Akinetic-rigid syndrome due to extrapontine and pontine myelinolysis following appropri... 5315218 - Pancreatic encephalopathy. 9250908 - Adenoma of the common human bile duct in gardner's syndrome may cause relapsing acute p... 21757888 - Acute promyelocytic leukemia with a smoldering course associated with therapy-related m... 10857668 - Foreign accent syndrome following a catastrophic second injury: mri correlates, linguis... 17978778 - Distraction osteogenesis in goldenhar syndrome: case report and 8-year follow-up. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical lymphoma, myeloma & leukemia Volume: 11 ISSN: 2152-2669 ISO Abbreviation: Clin Lymphoma Myeloma Leuk Publication Date: 2011 Aug |
Date Detail:
|
Created Date: 2011-08-05 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101525386 Medline TA: Clin Lymphoma Myeloma Leuk Country: United States |
Other Details:
|
Languages: eng Pagination: 303-13 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011. Published by Elsevier Inc. |
Affiliation:
|
Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postn...
Next Document: Consistency of FDG-PET Accuracy and Cost-Effectiveness in Initial Staging of Patients With Hodgkin L...